78 results
6-K
MREO
Mereo Biopharma Group Plc
26 May 22
Current report (foreign)
4:11pm
to Chair the Audit and Risk Committee
On May 25, 2022, the Board of Directors (the “Board”) of Mereo BioPharma Group plc (the “Company”) appointed … Anne Hyland to chair the Audit and Risk Committee. Ms. Hyland’s appointment follows Michael Wyzga’s resignation of chair of the Audit and Risk Committee
6-K
MREO
Mereo Biopharma Group Plc
3 Aug 20
Current report (foreign)
9:15am
opportunities.
As a result of Mr. Wyzga’s appointment to Interim Chief Financial Officer, Mr. Wyzga’s membership of the Audit and Risk Committee … of the board (the “Audit and Risk Committee”) will cease until a new Chief Financial Officer has been hired, though Mr. Wyzga will remain as an executive
6-K
MREO
Mereo Biopharma Group Plc
1 Oct 20
Current report (foreign)
4:30pm
, Mr. Michael Wyzga became Interim Chief Financial Officer of Mereo. As a result of that appointment, Mr. Wyzga’s membership on the Company’s Audit … and Risk Committee of the board (the “Audit and Risk Committee”) ceased. Mr. Wyzga continues to serve as an executive director of the board. As a result
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
the conclusion of the next annual general meeting at which the Company’s annual report and accounts are presented.
That the Audit and Risk Committee … those expressly stated.
Website Publication of Audit Concerns
Under Section 527 of the Companies Act 2006, members meeting the threshold
6-K
MREO
Mereo Biopharma Group Plc
1 Mar 22
Mereo BioPharma Announces Appointment of Anne Hyland to Board of Directors
9:55am
to the Board, effective immediately. Ms. Hyland was also appointed to serve on the Audit and Risk Committee of the Board. Ms. Hyland qualifies as independent … under the listing standards of the Nasdaq Global Market (“Nasdaq”).
Ms. Hyland is a non-executive director and Chair of the Audit and Risk Committee
6-K
fell5
10 Nov 22
Current report (foreign)
4:06pm
6-K
xsvgm16fp75ftgwdkg1
26 Oct 21
Current report (foreign)
4:16pm
6-K
6ioi7 kmf
20 Sep 23
Current report (foreign)
4:03pm
6-K
EX-99.1
18vp6bqk6baxs2
1 Mar 22
Mereo BioPharma Announces Appointment of Anne Hyland to Board of Directors
9:55am
6-K
EX-99.1
6enmz70 15g2uhb
20 Oct 20
Mereo BioPharma Appoints Christine Fox as Chief Financial Officer and Heidi Petersen as Senior Vice President, Regulatory Affairs
7:12am
10-K
r269023b59yfpba0fn
27 Mar 24
Annual report
5:20pm
10-K
EX-10.30
32qqk0onezoh
27 Mar 24
Annual report
5:20pm
F-4
EX-10.24
aa5i6kq2el4much udsl
25 Jan 19
Registration of securities (foreign)
12:00am
20-F
EX-12.2
l30 15nz44ihzi7
29 Apr 19
Annual report (foreign)
4:59pm
10-K
EX-31.1
bb4sv049
27 Mar 24
Annual report
5:20pm